Resources
for You and Your Team
Digital Mental Health Technology - The Quick Breakdown
In this rapid-fire breakdown, Nixon Law Group Senior Counsel Reema Taneja and Digital Health Expert Michael Schellhous cut through the noise to explain the critical shifts in Digital Mental Health Treatment (DMHT) codes.
They cover what the DMHT codes actually reimburse, how they fundamentally differ from Remote Patient Monitoring (RPM) and Remote Therapeutic Monitoring (RTM), and the strict FDA/CMS requirements your device must meet. They unpack the major hurdles—from the lack of a national payment amount (MAC contractor pricing) to provider uptake challenges—and advise founders on how to position their companies for success despite these limitations.
This video is an essential resource for founders looking to understand the pathway to reimbursement and influence the future of digital mental healthcare policy.
FDA Advisory Committee Signals New Regulatory Expectations for Generative AI in Digital Mental Health: What Innovators Need to Know Now
On November 6, 2025, the FDA’s Digital Health Advisory Committee delivered a clear message to the generative AI DMH sector: expect greater structure and tighter oversight. This article breaks down the 6 key themes—including the need for a new risk taxonomy, model drift management, and clinician-supervised use—and provides 5 immediate actions developers, deployers, and investors must prioritize to navigate the evolving regulatory landscape.